NIOSH recommendations for occupational safety and health stan-dards, 1988. MMWR1988;37 (Suppl 7):1–29.
2.
AndersonTJ, MeredithIT, GanzP, SelwynAP, YeungAC. Nitric oxide and nitrovasodilators: similarities, differences, and potential interactions. J Am Coll Cardiol1994;24(2):555–566.
3.
FriederichJA, ButterworthJFIV. Sodium nitroprusside: twenty years and counting. Anesth Analg1995;81(1):152–162.
4.
KoshlandDEJr. The molecule of the year (editorial). Science1992;258(5090):1861.
5.
AnggardE.Nitric oxide: mediator, murderer, and medicine. Lancet1994;343(8907):1199–1206.
6.
BilliarT.Nitric oxide. Novel biology with clinical relevance. Ann Surg1995;221(4):339–349.
7.
GastonB, DrazenJM, LoscalzoJ, StamlerJS. The biology of nitro-gen oxides in the airways. Am J Respir Crit Care Med1994;149(2, Part 1):538–551.
8.
KamP, GovenderG.Nitric oxide: basic science and clinical appli-cations. Anaesthesia1994;49(6):515–521.
9.
KavanaghB, PearlR.Inhaled nitric oxide in anesthesia and critical care medicine. Int Anesthesiol Clin1995;33(1):181–210.
10.
LunnR.Inhaled nitric oxide therapy. Mayo Clin Proc1995;70(3):247–255.
11.
MillerC, MillerJ.Pulmonary vascular smooth-muscle regulation: The role of inhaled nitric oxide gas. Respir Care1992;37:1175–1185.
12.
QuinnAC, PetrosAJ, VallanceP.Nitric oxide: an endogenous gas. Br J Anaesth1995;74(4):443–451.
13.
RossaintR, PisonU, GerlachH, FalkeK.Inhaled nitric oxide: its effects on pulmonary circulation and airway smooth muscle cells. Eur Heart J1993;14(Suppl):133–140.
14.
ZapolWM, HurfordWE. Inhaled nitric oxide in the adult respira-tory distress syndrome and other lung diseases. New Horiz1993;1(4):638–650.
15.
ZapolW, RimarS, GillisN, MarlettaM, BoskenCH. Nitric oxide and the lung. Am J Respir Crit Care Med1994;149(5):1375–1380.
16.
ZapolWM, FalkeKJ, HurfordWE, RobertsJDJr. Inhaling nitric oxide: a selective pulmonary vasodilator and bronchodilator. Chest 11994;105(3, Suppl):87S–91S.
17.
CioffiWGJr, OguraH.Inhaled nitric oxide in acute lung disease. New Horiz1995;3(1):73–85.
18.
MoncadaS, HiggsEA. Molecular mechanisms and therapeutic strate-gies related to nitric oxide. FASEB J1995;9(13):1319–1330.
19.
FurchgottR, ZawadzkiJ.The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature1980;288(5789):373–376.
20.
StuehrD, MarlettaM.Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proc Natl Acad Sci USA1985;82(22):7738–7742.
21.
PalmerRM, FerrigeAG, MoncadaS.Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature1987;327(6122):524–526.
22.
PalmerRM, ReesDD, AshtonDS, MoncadaS.L-arginine is the phys-iological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem Biophys Res Commun1988;153(3):1251–1256.
23.
MoncadaS, HiggsA.The L-arginine-nitric oxide pathway: mech-anisms of disease. N Engl J Med1993;329(27):2002–2012.
24.
MartinW, VillaniGM, JothianandanD, FurchgottRF. Selective block-ade of endothelium-dependent and glyceryl trinitrate-induced relax-ation by hemoglobin and by methylene blue in the rabbit aorta. J Phar-macol Exp Ther1985;232(3):708–716.
25.
IchinoseF, AdrieC, HurfordWE, ZapolWM. Prolonged pulmonary vasodilator action of inhaled nitric oxide by Zaprinast in awake lambs. J Appl Physiol1995;78(4):1288–1295.
26.
CobbJP, CunnionRE, DannerRL. Nitric oxide as a target for ther-apy in septic shock (editorial). Crit Care Med1993;21(9):1261–1263.
27.
BattafaranoRJ, DunnDL. Role of nitric oxide during sepsis (edi-torial). Crit Care Med1992;20(11):1504–1505.
28.
PastorC, TeisseireB, VicautE, PayenD.Effects of L-arginine and L-nitro-arginine treatment on blood pressure and cardiac output in a rabbit endotoxin shock model. Crit Care Med1994;22(3):465–469.
29.
LorenteJ, LandinL, dePabloR, RenesE, ListeD.L-arginine path-way in the sepsis syndrome. Crit Care Med1993;21(9):1287–1295.
30.
MeadowW, RudinskyB, BellA, HippsR.Effects of inhibition of endothelium-derived relaxation factor on hemodynamics and oxy-gen utilization during group B streptococcal sepsis in piglets. Crit Care Med1992;23:705–714.
31.
SchillingJ, CakmakciM, BattigU, GeroulanosS.A new approach in the treatment of hypotension in human septic shock by NG-monomethyl-L-arginine, an inhibitor of the nitric oxide synthetase. Intensive Care Med1993;19(4):227–231.
32.
MorrisSMJr, BilliarTR. New insights into the regulation of inducible nitric oxide synthesis. Am J Physiol1994;266(6, Part 1):E829–E839.
33.
StamlerJS, SingelDJ, LoscalzoJ.Biochemistry of nitric oxide and its redox-activated forms. Science1992;258(5090):1898–1902.
34.
PerssonMG, LonnqvistPA, GustafssonLE. Positive end-expiratory pressure ventilation elicits increases in endogenously formed nitric oxide as detected in air exhaled by rabbits. Anesthesiology1995;82(4):969–974.
35.
StewartTE, ValenzaF, RibeiroSP, WenerAD, VolgyesiG, MullenJB, SlutskyAS. Increased nitric oxide in exhaled gas as an early marker of lung inflammation in a model of sepsis. Am J Respir Crit Care Med1995;151(3, Part 1):713–718.
36.
HusainM, AdrieC, IchinoseF, KavosiM, ZapolWM. Exhaled nitric oxide as a marker for organic nitrate tolerance. Circulation1994;89(6):2498–2502.
37.
GustafssonL, LeoneA, PerssonM, WiklundN, MoncadaS.Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs, and humans. Biochem Biophys Res Commun1991;181(2):852–857.
38.
GerlachH, RossaintR, PappertD, KnorrM, FalkeKJ. Autoinhalation of nitric oxide after endogenous synthesis in nasopharynx. Lancet1994;343(8896):518–519.
39.
YokokawaK, MankusR, SaklayenMG, KohnoM, YasunariK, MinamiM, et al. Increased nitric oxide production in patients with hypoten-sion during hemodialysis. Ann Intern Med1995;123(1):35–37.
40.
HillGE, RuggeroliA, PohoreckiR, AlonsoA, RobbinsRA. Cigarette smoking reduces endogenous airway nitric oxide production during car-diopulmonary bypass in humans. Anesth Analg1995;81(1):170–172.
41.
KharitonovSA, WellsAU, O'ConnorBJ, ColePJ, HansellDM, Logan-SinclairRB, BarnesPJ. Elevated levels of exhaled nitric oxide in bronchiectasis. Am J Respir Crit Care Med1995;151(6):1889–1893.
42.
PerssonMG, WiklundNP, GustafssonLE. Endogenous nitric oxide in single exhalations and the change during exercise. Am Rev Respir Dis 11993; 148(5):1210–1214.
43.
BorlandC, CoxY, HigenbottamT.Measurement of exhaled nitric oxide in man. Thorax1993;48(11):1160–1162.
44.
SchillingJ, HolzerP, GuggenbachM, GyurechD, MarathiaK, Ger-oulanosS.Reduced endogenous nitric oxide in the exhaled air of smok-ers and hypertensives. Eur Respir J1994;7(3):467–471.
45.
KharitonovSA, O'ConnorBJ, EvansDJ, BarnesPJ. Allergen-induced late asthmatic reactions are associated with elevation of exhaled nitric oxide. Am J Respir Crit Care Med1995;151(6):1894–1899.
46.
PerssonM, ZetterstromO, AgreniusV, IhreE, GustafssonLE. Sin-gle-breath nitric oxide measurements in asthmatic patients and smok-ers. Lancet1994;343(8890):146–147.
47.
AlvingK, WeitzbergE, LundbergJ.Increased amount of nitric oxide in exhaled air of asthmatics. Eur Respir J1993;6(9):1368–1370.
48.
KharitonovSA, YatesD, RobbinsRA, Logan-SinclairR, ShinebourneEA, BarnesPJ. Increased nitric oxide in exhaled air of asthmatic patients. Lancet1994;343(8890):133–135.
49.
LundbergJ, Farkas-SzallasiT, WeitzbergE, et al. High nitric oxide production in human paranasal sinuses. Nature Med1995;1:370–373.
50.
WelteM, ZwisslerB, HabazettlH, MessmerK.PGI2 aerosol ver-sus nitric oxide for selective pulmonary vasodilation in hypoxic pul-monary vasoconstriction. Eur Surg Res1993;25(3):329–340.
51.
WetzelR.Aerosolized prostacyclin. in search of the ideal pulmonary vasodilator (editorial). Anesthesiology1995;82(6):1315–1317.
52.
BurghuberOC, SilberbauerK, HaberP, SinzingerH, ElliottM, Lei-thnerC.Pulmonary and antiaggretatory effects of prostacyclin after inhalation and intravenous infusion. Respiration1984;45(4):450–454.
53.
ZwisslerB, WelteM, MessmerK.Effects of inhaled prostacyclin as compared with inhaled nitric oxide on right ventricular performance in hypoxic pulmonary vasoconstriction. J Cardiothorac Vasc Anesth1995;9(3):283–289.
54.
ZwisslerB, RankN, JaenickeU, SchurleB, WelteM, ReichartB, et al. Selective pulmonary vasodilation by inhaled prostacyclin in a newborn with congenital heart disease and cardiopulmonary bypass. Anesthesiology1995;82(6):1512–1516.
PappertD, BuschT, GerlachH, LewandowskiK, RadermacherP.Aerosolized prostacyclin versus inhaled nitric oxide in children with severe acute respiratory distress syndrome. Anesthesiology1995;82(6):1507–1511.
57.
PutensenC, RasanenJ, DownsJB. Effect of endogenous and inhaled nitric oxide on the ventilation-perfusion relationships in oleic-acid lung injury. Am J Respir Crit Care Med1994;150(2):330–336.
58.
OguraH, SaitohD, JohnsonAA, MasonADJr, PruittBAJr, CioffiGWJr. The effect of inhaled nitric oxide on pulmonary ventilation-perfusion matching following smoke inhalation injury. J Trauma1994;37(6):893–898.
59.
OguraH, CioffiWG, OffnerPJ, JordanBS, JohnsonAA, PruittBAJr. Effect of inhaled nitric oxide on pulmonary function after sep-sis in a swine model. Surgery1994;116(2):313–321.
60.
PutensenC, RasanenJ, LopezFA, DownsJB. Continuous positive air-way pressure modulates effect of inhaled nitric oxide on the ventila-tion-perfusion distributions in canine lung injury. Chest1994;106(5):1563–1569.
61.
RossaintR, FalkeK.LopezF, SlamaK, PisonU, ZapolWM. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med1993;328(6):399–405.
62.
FrostellC, FratacciMD, WainJC, JonesR, ZapolWM. Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation1991;83(6):2038–2047. See the pub-lished erratum in Circulation 1991;84(5):2212.
63.
PisonU, LopezF, HeidelmeyerC, RossaintR, FalkeK.Inhaled nitric oxide reverses hypoxic pulmonary vasoconstriction without impair-ing gas exchange. J Appl Physiol1993;74(3):1287–1292.
64.
FrostellCG, BlomqvistH, HedenstiernaG, LundbergJ, ZapolWM. Inhaled nitric oxide selectively reverses human hypoxic pulmonary vasoconstriction without causing systemic vasodilation. Anesthesiology1993;78(3):427–435.
65.
RimarS, GillisCN. Selective pulmonary vasodilation by inhaled nitric oxide is due to hemoglobin inactivation. Circulation1993;88(6):2884–2887.
66.
RimarS, GillisCN. Site of pulmonary vasodilation by inhaled nitric oxide in the perfused lung. J Appl Physiol1995;78(5):1745–1749.
67.
ToothillC.The chemistry of the in vivo reaction between hemoglobin and various oxides of nitrogen. Br J Anaesth1967;39(5):405–412.
68.
IwamotoJ, KrasneyJA, MorinFCIII. Methemoglobin production by nitric oxide in fresh sheep blood. Respir Physiol1994;96(2-3):273–283.
69.
GibsonQ, RoughtonF.The kinetics of equilibria of the reactions of nitric oxide with sheep hemoglobin. J Physiol (Lond)1957;136:507–526.
70.
JacobTD, NakayamaDK, SekiI, ExlerR, LancasterJRJr, Sweet-landMA, et al. Hemodynamic effects and metabolic fate of inhaled nitric oxide in hypoxic piglets. J Appl Physiol1994;76(4):1794–1801.
71.
MurrayJF, MatthayMA, LuceJM, FlickMR. An expanded defi-nition of the adult respiratory distress syndrome. Am Rev Respir Dis1988;138(3):720–723. See the published erratum in Am Rev Respir Dis 1989;139(4):1065.
72.
DreyfussD, SolerP, BassetG, SaumanG.High inflation pressure pulmonary edema. Respective effects of high airway pressure, high tidal volume, and positive end-expiratory pressure. Am Rev Respir Dis1988;137(5):1159–1164.
73.
BigatelloL, HurfordWE, KacmarekRM, RobertsJDJr, ZapolWM. Prolonged inhalation of low concentrations of nitric oxide in patients with severe adult respiratory distress syndrome. Effects on pulmonary hemodynamics and oxygenation. Anesthesiology1994;80(4):761–770.
74.
ChannickR, NewhartJW, JohnsonFW, MoserKM. Inhaled nitric oxide reverses hypoxic pulmonary vasoconstriction in dogs. A prac-tical nitric oxide delivery and monitoring system. Chest1994;105(6):1842–1847.
75.
RoviraI, ChenTY, WinklerM, KawaiN, BlochKD, ZapolWM. Effects of inhaled nitric oxide on pulmonary hemodynamics and gas exchange in an ovine model of ARDS. J Appl Physiol1994;76(1):345–355.
76.
ShahNS, NakayamaDK, JacobTD, NishioI, ImaiT, BilliarTR, et al. Efficacy of inhaled nitric oxide in a porcine model of adult res-piratory distress syndrome. Arch Surg1994;129(2):158–164.
77.
KavanaghBP, MouchawarA, GoldsmithJ, PearlRG. Effects of inhaled NO and inhibition of endogenous NO synthesis in oxidant-induced acute lung injury. J Appl Physiol1994;76(3):1324–1329.
78.
GuidotDM, RepineMJ, HybertsonBM, RepineJE. Inhaled nitric oxide prevents neutrophil-mediated, oxygen radical-dependent leak in isolated rat lungs. Am J Physiol1995;269(1, Part 1):L2–L5.
79.
RossaintR, GerlachH, Schmidt-RuhnkeH, PappertD, LewandowskiK, SteudelW, FalkeK.Efficacy of inhaled nitric oxide in patients with severe ARDS. Chest1995;107(4):1107–1115.
80.
McIntyreR, MooreF, MooreE, PiedalueF, HaenelJ, FullertonD.Inhaled nitric oxide variably improves oxygenation and pulmonary hypertension in patients with acute respiratory distress syndrome. J Trauma1995;39:418–425.
81.
AbmanSH, GriebelJL, ParkerDK, SchmidtJM, SwantonD, Kin-sellaJP. Acute effects of inhaled nitric oxide in children with severe hypoxemic respiratory failure. J Pediatr1994;124(6):881–888.
82.
PuybassetL, StewartT, RoubyJJ, CluzelP, MourgeonE, BelinMF, et al. Inhaled nitric oxide reverses the increase in pulmonary vascular resistance induced by permissive hypercapnia in patients with acute respiratory distress syndrome. Anesthesiology1994;80(6):1254–1267.
83.
YoungJD, BramptonWJ, KnightonJD, FinferSR. Inhaled nitric oxide in acute respiratory failure in adults. Br J Anaesth1994;73(4):499–502.
84.
LevyB, BollaertPE, BauerP, NaceL, AudibertG, LarcanA.Ther-apeutic optimization including inhaled nitric oxide in adult respiratory distress syndrome in a polyvalent intensive care unit. J Trauma1995;38(3):370–374.
85.
FierobeL, BrunetF, DhainautJF, MonchiM, BelghithM, MiraJP, et al. Effect of inhaled nitric oxide on right ventricular function in adult respiratory distress syndrome. Am J Respir Crit Care Med1995;151(5):1414–1419.
86.
GerlachH, RossaintR, PappertD, FalkeKJ. Time-course and dose-response of nitric oxide inhalation for systemic oxygenation and pul-monary hypertension in patients with adult respiratory distress syn-drome. Eur J Clin Invest1993;23(8):499–502.
87.
WysockiM, DelclauxC, RoupieE, LangeronO, LiuN, HermanB, et al. Additive effect on gas exchange of inhaled nitric oxide and intra-venous almitrine bismesylate in the adult respiratory distress syn-drome. Intensive Care Med1994;20(4):254–259.
88.
GerlachH, PappertD, LewandowskiK, RossaintR, FalkeKJ. Long-term inhalation with evaluated low doses of nitric oxide for selec-tive improvement of oxygenation in patients with adult respiratory distress syndrome. Intensive Care Med1993;19(8):443–449.
89.
PuybassetL, RoubyJJ, MourgeonE, StewartTE, CluzelP, ArthaudM, et al. Inhaled nitric oxide in acute respiratory failure: dose-response curves. Intensive Care Med1994;20(5):319–327.
90.
PuybassetL, RoubyJJ, MourgeonE, CluzelP, SouhilZ, Law-KouneJD, et al. Factors influencing cardiopulmonary effects of inhaled nitric oxide in acute respiratory failure. Am J Respir Crit Care Med1995;152(1):318–328.
91.
KainML. Higher oxides of nitrogen in anaesthetic gas circuits. Br J Anaesth1967;39(5):382–387.
92.
AustinAT. The chemistry of higher oxides of nitrogen as related to the manufacture, storage and administration of nitrous oxide. Br J Anaesth1967;39(5):345–350.
93.
GlassonWA, TuesdayCS. The atmospheric thermal oxidation of nitric oxide. J Am Chem Soc1963;85:2901–2904.
94.
BouchetM, RenaudinMH, RaveauC, MercierJC, DehanM, ZupanV.Safety requirement for use of inhaled nitric oxide in neonates (let-ter). Lancet1993;341(8850):968–969.
95.
FoubertL, FlemingB, LatimerR, JonasM, OduroA, BourlandC, HiggenbottamT.Safety guidelines for use of nitric oxide (letter). Lancet1992;339(8809):1615–1616.
96.
MiyamotoK, AidaA, NishimuraM, NakanoT, KawakamiY, OhmoriY, et al. Effects of humidity and temperature on nitrogen dioxide for-mation from nitric oxide. Lancet1994;343(8905):1099–1100.
97.
FramptonMW, MorrowPE, CoxC, GibbFR, SpeersDM, UtellMJ. Effects of nitrogen dioxide exposure on pulmonary function and air-way reactivity in normal humans. Am Rev Respir Dis1991;143(3):522–527.
98.
StephensRJ, FreemanG, EvansMJ. Early response of lungs to low levels of nitrogen dioxide. Light and electron microscopy. Arch Env-iron Health1972;24(3):160–179.
99.
NishimuraM, HessD, KacmarekRM, RitzR, HurfordWE. Nitro-gen dioxide production during mechanical ventilation with nitric oxide in adults. Effects of ventilator internal volume, air versus nitrogen dilution, minute ventilation, and inspired oxygen fraction. Anes-thesiology1995;82(5):1246–1254.
100.
GongHJr. Health effects of air pollution. A review of clinical stud-ies. Clin Chest Med1992;13(2):201–214.
101.
ShielFO. Morbid anatomical changes in the lungs of dogs after inhala-tion of higher oxides of nitrogen during anaesthesia. Br J Anaesth1967;39(5):413–424.
102.
GreenbaumR, BayJ, HargreavesMD, KainML, KelmanGR, NunnJF, et al. Effects of higher oxides of nitrogen on the anaesthetized dog. Br J Anaesth1967;39(5):393–403.
103.
WilliamsRA, RhoadesRA, AdamsWS. The response of lung tis-sue and surfactant to nitrogen dioxide exposure. Arch Intern Med1971;128(1):101–108.
104.
FreemanG, CraneSC, FuriosiNJ, StephensRJ, EvansMJ, MooreWD. Covert reduction in ventilatory surface in rats during prolonged exposure to subacute nitrogen dioxide. Am Rev Respir Dis1972;106(4):563–579.
105.
EvansMJ, StephensRJ, CabralLJ, FreemanG.Cell renewal in the lungs of rats exposed to low levels of NO2. Arch Environ Health1972;24(3):180–188.
106.
RasmussenTR, KjaergaardSK, TarpU, PedersenOF. Delayed effects of NO2 exposure on alveolar permeability and glutathione peroxi-dase in healthy humans. Am Rev Respir Dis1992;146(3):654–659.
107.
BylinG, HedenstiernaG, LindvallT, SundinB.Ambient nitrogen dioxide concentrations increase bronchial responsiveness in subjects with mild asthma. Eur Respir J1988;1(7):606–612.
108.
MorrowPE, UtellMJ, BauerMA, SmeglinAM, FramptonMW, CoxC, et al. Pulmonary performance of elderly normal subjects with chronic obstructive pulmonary disease exposed to 0.3 ppm nitrogen diox-ide. Am Rev Respir Dis1992;145(2, Part 1):291–300.
109.
PostlethwaitEM, LangfordSD, BidaniA.Kinetics of NO2 air space absorption in isolated rat lungs. J Appl Physiol1992;73(5):1939–1945.
110.
AidaA, MiyamotoK, SaitoS, NakanoT, NishimuraM, KawakamiY, et al. Effects of temperature and humidity on the stability of nitric oxide, and efficiency of soda lime as a selective absorber of nitrogen dioxide. Nippon Kyobu Shikkan Gakkai Zasshi1995;33(3):306–311.
111.
StenqvistO, KjelltoftB, LundinS.Evaluation of a new system for ventilatory administration of nitric oxide. Acta Anaesthesiol Scand1993;37(7):687–691.
112.
PickettJA, MoorsAH, LatimerRD, MahmoodN, GhoshS, OduroA.The role of soda lime during administration of inhaled nitric oxide. Br J Anaesth1994;72(6):683–685.
113.
CurryS.Methemoglobinemia. Ann Emerg Med1982;11(4):214–221.
114.
ZijlstraWG, BuursmaA, Meeuwsen van der RoestWP. Absorp-tion spectra of human fetal and adult oxyhemoglobin, de-oxyhe-moglobin, carboxyhemoglobin, and methemoglobin. Clin Chem1991;37(9):1633–1638.
115.
SeveringhausJW, KelleherJF. Recent developments in pulse oxime-try. Anesthesiology1992;76(6):1018–1038.
116.
AzoulayE, LachiaL, BlayoMC, PocidaloJJ. Methaemoglobine-mia induced by nitric oxide in whole blood. Quantitative relation-ship. Toxicol Eur Res1978;1(1):7–12.
117.
DoyleMP, PickeringRA, DeWeertTM, HoekstraJW, PaterD.Kinet-ics and mechanism of the oxidation of human deoxyhemoglobin by nitrites. J Biol Chem1981;256(23):12393–12398.
118.
KonK, MaedaN, ShigaT.Effect of nitric oxide on the oxygen trans-port of human erythrocytes. J Toxicol Environ Health1977;2(5):1109–1113.
119.
MaedaN, ImaizumiK, KonK, ShigaT.A kinetic study on functional impairment of nitric oxide-exposed rat erythrocytes. Environ Health Perspect1987;73:171–177.
120.
WennmalmA, BenthinG, EdlundA, JungerstenL, Kieler-JensenN, LundinS, et al. Metabolism and excretion of nitric oxide in humans. An experimental and clinical study. Circ Res1993;73(6):1121–1127.
121.
AzoulayE, SolerP, BlayoMC, BassetF.Nitric oxide effects on lung structure and blood oxygen affinity in rats. Bull Eur Physiopathol Respir1977;13(5):629–644.
122.
HeadCA, RitzR, HurfordWE, AlfillePH, HessD, ZapolWM. Low methemoglobin concentrations in humans during prolonged expo-sure to nitric oxide (abstract). Am J Respir Crit Care Med1994;149:A568.
123.
YoungJD, DyarOJ, XiongL, ZhangJ, GavaghanD.Effect of methy-lene blue on the vasodilator action of inhaled nitric oxide in hypoxic sheep. Br J Anaesth1994;73(4):511–516.
124.
FreemanB.Free radical chemistry of nitric oxide. Looking at the dark side. Chest1994;105(3, Suppl):79S–84S.
125.
KooyNW, RoyallJA. Agonist-induced peroxynitrite production from endothelial cells. Arch Biochem Biophys 11994;310(2):352–359.
126.
MellionBT, IgnarroLJ, OhlsteinEH, PontecorvoEG, HymanAL, Kad-owitzPJ. Evidence for the inhibitory role of guanosine 3', 5’ monophos-phate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators. Blood1981;57(5):946–955.
127.
RadomskiMW, PalmerRM, MoncadaS.Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide, and prostacy-clin in platelets. Br J Pharmacol1987;92(1):181–187.
128.
RadomskiMW, MoncadaS.Regulation of vascular homeostasis by nitric oxide. Thromb Haemost1993;70(1):36–41.
129.
LoscalzoJ.Antiplatelet and antithrombotic effect of organic nitrates. Am J Cardiol1992;70(8):18B–22B.
130.
WeberAA, StrobachH, SchrorK.Direct inhibition of platelet func-tion by organic nitrates via nitric oxide formation. Eur J Pharmacol1993;247(1):29–37.
131.
BassengeE.Antiplatelet effects of endothelium-derived relaxing fac-tor and nitric oxide donors. Eur Heart J 11991;12(Suppl E):12–15.
132.
HogmanM, FrostellC, ArnbergH, SandhagenB, HedenstiernaG.Prolonged bleeding time during nitric oxide inhalation in the rabbit. Acta Physiol Scand1994;151(1):125–129.
133.
HogmanM, FrostellC, ArnbergH, HedenstiernaG.Bleeding time prolongation and NO inhalation (letter). Lancet1993;341(8861):1664–1665.
134.
SamamaCM, DiabyM, FellahiJL, MdhafarA, EyraudD, ArockM, et al. Inhibition of platelet aggregation by inhaled nitric oxide in patients with acute respiratory distress syndrome. Anesthesiology1995;83(1):56–65.
135.
LohE, StamlerJS, HareJM, LoscalzoJ, ColucciWS. Cardiovascular effects of inhaled nitric oxide in patients with left ventricular dysfunction. Circulation1994;90(6):2780–2785.
136.
BocchiEA, BacalF, AulerJO, CarmoneMJ, BellottiG, PileggiF.Inhaled nitric oxide leading to pulmonary edema in stable severe heart failure. Am J Cardiol1994;74(1):70–72.
137.
SemigranMJ, CockrillBA, KacmarekR, ThompsonBT, ZapolWM, DecGW, FiferMA. Hemodynamic effects of inhaled nitric oxide in heart failure. J Am Coll Cardiol1994;24(4):982–988.
138.
MillerOl, TangSF, KeechA, CelermajerDS. Rebound pulmonary hypertension on withdrawal from inhaled nitric oxide (letter). Lancet1995;346(8966):51–52.
139.
KiffRJ, MossDW, MoncadaS.Effect of nitric oxide gas on the generation of nitric oxide by isolated blood vessels: implications for inhalation therapy. Br J Pharmacol1994;113(2):496–498.
140.
AssreuyJ, CunhaFQ, LiewFY, MoncadaS.Feedback inhibition of nitric oxide synthase activity by nitric oxide. Br J Pharmacol1993;108(3):833–837.
141.
HessD, KacmarekRM, RitzR, BigatelloLM, HurfordWE. Inhaled nitric oxide delivery systems: A role for respiratory therapists (editorial). Respir Care1995;40:702–705.
142.
WatkinsDN, JenkinsIR, RankinJM, ClarkeGM. Inhaled nitric oxide in severe acute respiratory failure its use in intensive care and description of a delivery system. Anaesth Intensive Care1993;21(6):861–866.
143.
PutensenC, RasanenJ, ThomsonMS, BramanRS. Method of delivering constant nitric oxide concentrations during full and partial ventilatory support. J Clin Monit1995;11(1):23–31.
144.
TibballsJ, HochmannM, CarterB, OsborneA.An appraisal of techniques for administration of gaseous nitric oxide. Anaesth Intensive Care1993;21(6):844–847.
145.
WesselDL, AdatiaI, ThompsonJE, HickeyPR. Delivery and monitoring of inhaled nitric oxide in patients with pulmonary hypertension. Crit Care Med1994;22(6):930–938.
146.
GraybealJ, SchulerGH, LarachDR. Instability of nitric oxide concentration delivered from a two-blender system (letter). Crit Care Med1995;23(9):1611–1612.
147.
BetitP, AdatiaI, BenjaminP, ThompsonJE, WesselDL. Inhaled nitric oxide: Evaluation of a continuous titration delivery technique for infant mechanical and manual ventilation. Respir Care1995;40:706–715.
148.
MillerOI, CelermajerDS, DeanfieldJE, MacraeDJ. Guidelines for the safe administration of inhaled nitric oxide. Arch Dis Child Fetal Neonatal Ed1994;70(1):F47–F49.
149.
SkimmingJW, CassinS, BlanchPB. Nitric oxide administration using constant-flow ventilation. Chest1995;108(4):1065–1072.
150.
StrongK, HessD, RitzR, NishimuraM, KacmarekRM. Administration of nitric oxide with a continuous flow infant ventilator (abstract). Respir Care1994;39:1113.
151.
RitzR, HessD, HeadCA, KacmarekRM. Nitric oxide (NO) and nitrogen dioxide (NO2) levels during manual ventilation (abstract). Respir Care1995;40:1184.
152.
SnellGI, SalamonsenRF, BerginP, EsmoreDS, KhanS, WilliamsTJ. Inhaled nitric oxide used as a bridge to heart-lung transplantation in a patient with end-stage pulmonary hypertension. Am J Respir Crit Care Med1995;151(4):1263–1266.
153.
HessD, KacmarekR, ImanakaH, BigatelloL, HurfordW.Administration of inhaled nitric oxide by nasal cannula (abstract). Am J Respir Crit Care Med1995;151:A44.
154.
BlackF, SigsbyJ.Chemiluminescent method for NO and NOx (NO + NO2) analysis. Environ Sci Technol1974;8:149–152.
155.
FontijinA, SabadellAJ, RonocoRJ. Homogeneous chemiluminescent measurement of nitric oxide with ozone. Anal Chem1970;42:575–579.
MatthewsRD, SawyerRF, ScheferRW. Interferences in chemiluminescent measurement of NO and NO2 emissions from combustion systems. Envir Sci Technol1977;12:1092–1096.
158.
ZableiskiMF, SeeryDJ, DodgeLG. Influence of mass transport and quenching on nitric oxide chemiluminescent analysis. Envir Sci Technol1984;18:88–92.
159.
MillerCC. Chemiluminescence analysis and nitrogen dioxide measurement (letter). Lancet1994;343(8892):300–301.
BetitP, GrenierB, ThompsonJ.Evaluation of four nitric oxide therapy analyzers using known concentrations of nitrogen dioxide (abstract). Respir Care1995;40:1186.
164.
BetitP, GrenierB, ThompsonJ.Evaluation of four analyzers to monitor inhaled nitric oxide therapy (abstract). Respir Care1995;40:1187.
165.
MercierJC, ZupanV, DehanM, RenaudinMH, BouchetM, RaveauC.Device to monitor concentration of inhaled nitric oxide. Lancet1993;342(8868):431–432.
166.
PetrosAJ, CoxPB, BohnD.Simple method for monitoring concentration of inhaled nitric oxide (letter). Lancet1992;340(8828):1167.
167.
PetrosAJ, CoxP, BohnD.A simple method for monitoring the concentration of inhaled nitric oxide. Anaesthesia1994;49(4):317–319.
168.
MoutafisM, HatahetZ, CastelainMH, RenaudinMH, MonnotA, FischlerM.Validation of a simple method assessing nitric oxide and nitrogen dioxide concentrations. Intensive Care Med1995;21(6):537–541.
169.
EtchesP, HarrisM, McKinleyR, FinerN.Clinical monitoring of inhaled nitric oxide: Comparison of chemiluminescent and electrochemical sensors. Biomedical Instrum Technol1995;29(2):134–140.
170.
NishimuraM, TashiroC, FujinoY, ImanakaH, HessD, KacmarekRM. Response of chemiluminescent analyzers on the measured value of nitric oxide (NO) (abstract). Respir Care1995;40:1186.
171.
HessD, KacmarekRM, HurfordWE. Inspired versus tracheal [NO] (abstract). Respir Care1995;40:1185.
